Christine Wang, Bridgeway – “Room To Run” with US Small-Cap Value Stocks? (The Best Investment Writing Volume 6)

Episode Summary

Executive Summary: This episode presents Bridgeway Capital Management’s case that U.S. small-cap value stocks, after years of severe underperformance, still have substantial room to outperform large-cap growth on a relative valuation basis. Using historical size and book-to-market data, the speakers argue that the factor’s recent rebound has not erased the discount, and that investors with long-term horizons should maintain or restore small-value exposure rather than try to time the cycle.

Main Topics: Episode framing and sponsor context (Priority: 2/5): The show is part of a series highlighting top investment writing, with sponsor messages from Cambria and Bridgeway/AlphaSense-related charitable support before the main reading begins. The resurgence of small-cap value after years of lagging (Priority: 5/5): The transcript contrasts strong recent performance in small-cap value with the prior multi-year stretch of deep underperformance against large-cap growth. Size factor recovery versus long-term underperformance (Priority: 5/5): Bridgeway argues that the size factor has rebounded strongly, but the long-term record still suggests small stocks remain below their historical premium and may have more room to run. Valuation gap remains wide for small-cap value (Priority: 5/5): Using book-to-market comparisons, the speakers claim small-cap value is still meaningfully cheaper than the broader market and would need a large relative price increase to normalize. Why this is not a timing call (Priority: 4/5): The authors repeatedly stress they are not forecasting a short-term winner, but advocating disciplined factor allocation and rebalancing based on long-term expected premiums. Macro conditions that could favor value (Priority: 3/5): Potential tailwinds cited include recovery from the pandemic, fiscal stimulus, infrastructure spending, and rising interest rates, all of which could support value over growth. 2022 addendum confirming relative cheapness (Priority: 4/5): A later update notes that after market declines in 2022, small-cap value became even cheaper versus the S&P 500 than it was in 2021, reinforcing the original thesis.

Key Arguments: Small-cap value suffered a long period of underperformance, but recent gains have not fully repaired the valuation discount versus large-cap equities. The size factor has recovered sharply, yet its long-term record still implies room for further mean reversion. Relative book-to-market valuation suggests small-cap value would need to rise substantially versus the broad market to return to historical norms. Bridgeway’s view is not a market-timing call; it is a case for maintaining strategic factor exposures and rebalancing when portfolios drift. Investors who chased large growth stocks may now be underexposed to small-value stocks and should consider adding exposure. A combination of economic recovery, fiscal stimulus, market corrections, and higher rates could further support value stocks over growth. The 2022 market drawdown made small-value look even cheaper on a relative basis, strengthening the long-term case rather than undermining it.

Data Points: Russell 2000 Value vs. S&P 500 underperformance: ~10 percentage points per year for four consecutive years (2017-2020) - Describes the multi-year lag of small-cap value relative to large-cap U.S. stocks. Large-cap growth outperformance in 2020: More than 33% - Large growth stocks beat small-cap value by a wide margin during the 2020 market environment. Trailing 3-year size factor performance (as of Q1 2020): Smallest decile lagged largest by over 15% annually - Illustrates how weak small-company performance had become before the rebound. Trailing 3-year size factor performance (as of Q1 2021): Smallest stocks outperformed larger peers by over 3% annually - Shows the speed and magnitude of the subsequent recovery in the size factor. Long-term size factor record: 10- and 15-year periods still negative as of Q1 2021 - Despite the rebound, the long horizon had not yet fully recovered. 10-year small-stock underperformance: Almost 1.3% - Used to argue small stocks would need to outperform for a while to restore historical premiums. Required relative price increase for small value: 43% - Estimated rise needed in small-cap value prices relative to the broader U.S. market to reach median historical valuation. Historical valuation ratio: 2.1 as of March 31, 2021; 2.4 as of June 30, 2022 - Update showing small-cap value became cheaper relative to the S&P 500 after the 2022 selloff. Relative valuation interpretation: Still significantly cheaper than historical average - 2022 addendum argues the discount persisted and even widened relative to the broad market.

Pivotal Quotes: "small value stocks still have room to run" — Bridgeway Capital Management: Core thesis of the piece: despite the rebound, the factor remains attractive on a long-term relative basis. "the problem is a very cheap investment can always get cheaper" — John Montgomery's Harvard Business School professor (quoted by the speaker): Used to acknowledge valuation can overshoot and to caution against treating the analysis as a short-term timing signal. "we do believe in establishing a long-term plan with specific factor exposures, sticking with the plan through thick and thin" — Bridgeway Capital Management: Summarizes the firm’s disciplined, non-tactical approach to factor investing.

Implications: Listeners should view small-cap value as a long-term allocation question, not a short-term trade. The episode argues portfolios may need rebalancing toward small value, especially after years of growth-stock dominance.